Pays: Royaume-Uni
Langue: anglais
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Achète-le
Methotrexate
DE Pharmaceuticals
L04AX03
50mg/1ml
Solution for injection
Subcutaneous
No Controlled Drug Status
Caution - AMP level prescribing advised
BNF: 10010300